Keyphrases
Feature-based
100%
Fluorescence in Situ Hybridization
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Diagnostic Methods
100%
Anaplastic Lymphoma Kinase Fusion
100%
Anaplastic Lymphoma Kinase
80%
Immunohistochemistry
60%
Genome Sequence Analysis
60%
Tumor
20%
Korean Patients
20%
Oncogenesis
20%
Lung Cancer
20%
In Cancer
20%
Cancer-related
20%
Genetic Modification
20%
Genetic mutation
20%
Malignancy
20%
Tumor Stage
20%
Biological Markers
20%
Female Patients
20%
Advanced Stage
20%
Next-generation Sequencing
20%
Histological Subtypes
20%
Young Age
20%
Cancer Causes
20%
EGFR mutation
20%
Effective Treatment
20%
Therapeutic Response
20%
DNA Modification
20%
Genetic Changes
20%
Growth Drivers
20%
Smoking History
20%
Fluorescence in Situ Hybridization Analysis
20%
Nodal Metastasis
20%
New Drug Targets
20%
Driver mutations
20%
Immunohistochemical Profile
20%
RNA Alteration
20%
Fusion Detection
20%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Diagnosis
100%
Anaplastic Lymphoma Kinase
100%
Fluorescence in Situ Hybridization
66%
Next Generation Sequencing
44%
Gene Mutation
33%
Malignant Neoplasm
33%
Immunohistochemistry
33%
Biological Marker
11%
Lung Cancer
11%
Neoplasm
11%
Cancer
11%
Carcinogenesis
11%
Cancer Staging
11%
Epidermal Growth Factor Receptor
11%
Treatment Response
11%
Nodal Metastasis
11%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Anaplastic Lymphoma Kinase
100%
Malignant Neoplasm
33%
Neoplasm
11%
Carcinogenesis
11%
Epidermal Growth Factor Receptor
11%
Biological Marker
11%
Lung Cancer
11%
Cancer Staging
11%
Biochemistry, Genetics and Molecular Biology
Anaplastic Lymphoma Kinase
100%
Fluorescence in Situ Hybridization
66%
Next Generation Sequencing
44%
Gene Mutation
33%
Epidermal Growth Factor Receptor
11%
Carcinogenesis
11%
RNA
11%
Cancer Staging
11%